Trial Profile
Stress and the At-Risk Employee: a Long-Term Study of Eprosartan in Comparison to Standard Therapy
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 14 Aug 2007
Price :
$35
*
At a glance
- Drugs Eprosartan (Primary) ; ACE inhibitors; Beta-adrenergic receptor antagonists
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms STARLET
- 01 Sep 2006 New trial record.